Exact Mass: 614.0277

Exact Mass Matches: 614.0277

Found 25 metabolites which its exact mass value is equals to given mass value 614.0277, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Castacrenin A

12-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


Castacrenin A is found in nuts. Castacrenin A is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

   

Castacrenin C

6,7,13,14-tetrahydroxy-5-[5,6,7-trihydroxy-1-oxo-3-(1,2,3,4-tetrahydroxybutyl)-1H-isochromen-8-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


Castacrenin C is found in nuts. Castacrenin C is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

   

Castacrenin B

6,7,13,14-tetrahydroxy-12-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(10),11,13-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


Castacrenin B is found in nuts. Castacrenin B is a constituent of the heartwood of Castanea crenata (Japanese chestnut)

   

Lifitegrast

(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid

C29H24Cl2N2O7S (614.0681)


   
   
   

N-[3-Bromo-5-iodo-4-[3-[(1-oxo-3-methyl-2-butenyl)amino]propoxy]phenethyl]-4-hydroxybenzeneacetamide

N-[3-Bromo-5-iodo-4-[3-[(1-oxo-3-methyl-2-butenyl)amino]propoxy]phenethyl]-4-hydroxybenzeneacetamide

C24H28BrIN2O4 (614.0277)


   
   

Castacrenin A

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


   

Castacrenin B

6,7,13,14-tetrahydroxy-5-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0^{2,7}]tetradeca-1(10),11,13-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


   

Castacrenin C

6,7,13,14-tetrahydroxy-5-[5,6,7-trihydroxy-1-oxo-3-(1,2,3,4-tetrahydroxybutyl)-1H-isochromen-8-yl]-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


   

Samarium,tris(1,1,1-trifluoro-2,4-pentanedionato-kO,kO)- (9CI)

Samarium,tris(1,1,1-trifluoro-2,4-pentanedionato-kO,kO)- (9CI)

C15H15F9O6Sm (613.9922)


   

sodium 3-[methyl[3-[[(tridecafluorohexyl)sulphonyl]amino]propyl]amino]propanesulphonate

sodium 3-[methyl[3-[[(tridecafluorohexyl)sulphonyl]amino]propyl]amino]propanesulphonate

C13H16F13N2NaO5S2 (614.0191)


   

Lifitegrast

Lifitegrast

C29H24Cl2N2O7S (614.0681)


D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions C78283 - Agent Affecting Organs of Special Senses S - Sensory organs > S01 - Ophthalmologicals

   
   

3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-Tricosafluorotridecan-1-ol

3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,13-Tricosafluorotridecan-1-ol

C13H5F23O (613.9973)


   

GDP-N-formyl-alpha-D-perosamine

GDP-N-formyl-alpha-D-perosamine

C17H24N6O15P2-2 (614.0775)


   

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

5-[4-(1,2-dihydroxyethyl)-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C27H18O17 (614.0544)


   

(1s,2s,4r,12s,13r,15r,16s)-2-bromo-8-[(2r,3s)-1,1-dichloro-3-hydroxy-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

(1s,2s,4r,12s,13r,15r,16s)-2-bromo-8-[(2r,3s)-1,1-dichloro-3-hydroxy-3-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

C27H29BrCl2O7 (614.0474)


   

6,7,13,14-tetrahydroxy-5-{5,6,7-trihydroxy-1-oxo-3-[(1s,2r,3r)-1,2,3,4-tetrahydroxybutyl]isochromen-8-yl}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

6,7,13,14-tetrahydroxy-5-{5,6,7-trihydroxy-1-oxo-3-[(1s,2r,3r)-1,2,3,4-tetrahydroxybutyl]isochromen-8-yl}-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione

C27H18O17 (614.0544)


   

2-bromo-8-[1,1-dichloro-3-hydroxy-3-(4-methyl-5-oxooxolan-2-yl)propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

2-bromo-8-[1,1-dichloro-3-hydroxy-3-(4-methyl-5-oxooxolan-2-yl)propan-2-yl]-16-hydroxy-9,13-dimethyl-18-oxapentacyclo[13.2.1.0¹,¹³.0⁴,¹².0⁵,¹⁰]octadeca-5(10),6,8-triene-11,17-dione

C27H29BrCl2O7 (614.0474)


   

6,7,13,14-tetrahydroxy-5-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

6,7,13,14-tetrahydroxy-5-[5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C27H18O17 (614.0544)


   

n-{3-[2-bromo-4-(2-{[1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}ethyl)-6-iodophenoxy]propyl}-3-methylbut-2-enimidic acid

n-{3-[2-bromo-4-(2-{[1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}ethyl)-6-iodophenoxy]propyl}-3-methylbut-2-enimidic acid

C24H28BrIN2O4 (614.0277)


   

5-[(2r,4r,5s,6r)-4-[(1r)-1,2-dihydroxyethyl]-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

5-[(2r,4r,5s,6r)-4-[(1r)-1,2-dihydroxyethyl]-5,11,12,13-tetrahydroxy-8-oxo-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-10-yl]-6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C27H18O17 (614.0544)


   

6,7,13,14-tetrahydroxy-5-[(2r,4r,5s,6s,7r)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

6,7,13,14-tetrahydroxy-5-[(2r,4r,5s,6s,7r)-5,6,12,13,14-pentahydroxy-4-(hydroxymethyl)-9-oxo-3,8-dioxatricyclo[8.4.0.0²,⁷]tetradeca-1(14),10,12-trien-11-yl]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione

C27H18O17 (614.0544)